Publications
2024
Why is single sample rule out of non-ST elevation myocardial infarction using high-sensitivity cardiac troponin T safe when analytical imprecision is so high? A joint statistical and clinical demonstration.
Hatherley, J. D., Miller, G., Collinson, P., Shantsila, E., Fearon, H., Lambert, A., . . . Khand, A. (2024). Why is single sample rule out of non-ST elevation myocardial infarction using high-sensitivity cardiac troponin T safe when analytical imprecision is so high? A joint statistical and clinical demonstration.. Clinical chemistry and laboratory medicine. doi:10.1515/cclm-2024-0647
A qualitative exploration of barriers to efficient and effective structured medication reviews in primary care: Findings from the DynAIRx study.
Abuzour, A. S., Wilson, S. A., Woodall, A. A., Mair, F. S., Clegg, A., Shantsila, E., . . . Walker, L. E. (2024). A qualitative exploration of barriers to efficient and effective structured medication reviews in primary care: Findings from the DynAIRx study.. PloS one, 19(8), e0299770. doi:10.1371/journal.pone.0299770
For Debate: The 2023 European Society of Hypertension guidelines - cause for concern.
Shantsila, E., Beevers, D. G., & Lip, G. Y. H. (2024). For Debate: The 2023 European Society of Hypertension guidelines - cause for concern.. Journal of hypertension, 42(6), 948-950. doi:10.1097/hjh.0000000000003733
Emergence of nephrocardiology: Integrating management of cardiovascular and kidney diseases for holistic patient care.
Dzeshka, M. S., Shantsila, A., Lip, G. Y. H., & Shantsila, E. (2024). Emergence of nephrocardiology: Integrating management of cardiovascular and kidney diseases for holistic patient care.. Trends in cardiovascular medicine, S1050-1738(24)00033-1. doi:10.1016/j.tcm.2024.04.002
Secondary prevention of cardiovascular disease, including cholesterol targets: summary of updated NICE guidance.
Wonderling, D., Mariani, A., Samarasekera, E. J., Wilkinson, C., Patel, R. S., Mills, J., & Guideline Committee. (2024). Secondary prevention of cardiovascular disease, including cholesterol targets: summary of updated NICE guidance.. BMJ (Clinical research ed.), 384, q637. doi:10.1136/bmj.q637
How to measure blood pressure: focus on general practice.
Shantsila, E., & Clark, C. (2024). How to measure blood pressure: focus on general practice.. The British journal of general practice : the journal of the Royal College of General Practitioners, 74(740), 140-142. doi:10.3399/bjgp24x736689
Atrial fibrillation: comorbidities, lifestyle, and patient factors.
Shantsila, E., Choi, E. -K., Lane, D. A., Joung, B., & Lip, G. Y. H. (2024). Atrial fibrillation: comorbidities, lifestyle, and patient factors.. The Lancet regional health. Europe, 37, 100784. doi:10.1016/j.lanepe.2023.100784
2023
Better blood pressure control in patients with atrial fibrillation: overcoming barriers to improve outcomes
Dzeshka, M. S., Shantsila, A., Shantsila, E., & Lip, G. Y. H. (2023). Better blood pressure control in patients with atrial fibrillation: overcoming barriers to improve outcomes. HEART. doi:10.1136/heartjnl-2023-323028
How might dynamic artificial intelligence (DynAIRx) be used to support prescribing to ensure efficient medication reviews?
Abuzour, A., Wilson, S., Woodall, A., Mair, F., Bollegala, D., Cant, H., . . . Walker, L. (2023). How might dynamic artificial intelligence (DynAIRx) be used to support prescribing to ensure efficient medication reviews?. American Academy of Family Physicians. doi:10.1370/afm.22.s1.4823
Interaction of Heart Failure and Stroke: A clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on Thrombosis.
Doehner, W., Böhm, M., Boriani, G., Christersson, C., Coats, A. J., Haeusler, K. G., . . . Rosano, G. (2023). Interaction of Heart Failure and Stroke: A clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on Thrombosis.. European journal of heart failure. doi:10.1002/ejhf.3071
Management of ischaemic stroke survivors in primary care setting: the road to holistic care
Ozdemir, H., Sagris, D., Abdul Rahim, A. H., Lip, G., & Shantsila, E. (2023). Management of ischaemic stroke survivors in primary care setting: the road to holistic care. Internal and Emergency Medicine.
Left ventricular hypertrophy and mortality in ethnic minority groups in the UK: e-ECHOES study.
Shantsila, E., Shantsila, A., Williams, N., Lip, G. Y. H., & Gill, P. S. (2023). Left ventricular hypertrophy and mortality in ethnic minority groups in the UK: e-ECHOES study.. Journal of hypertension. doi:10.1097/hjh.0000000000003561
Beyond individual risk factors in atrial fibrillation: The interactions of hypertension and sex.
Shantsila, E., Shantsila, A., & Lip, G. Y. H. (2023). Beyond individual risk factors in atrial fibrillation: The interactions of hypertension and sex.. American journal of hypertension, hpad069. doi:10.1093/ajh/hpad069
Antihypertensive treatment in people of very old age with frailty: time for a paradigm shift?
Shantsila, E., Lip, G. Y. H., Shantsila, A., Kurpas, D., Beevers, G., Gill, P. S., & Williams, N. H. (2023). Antihypertensive treatment in people of very old age with frailty: time for a paradigm shift?. Journal of Hypertension, 4(10), 1502-1510. doi:10.1097/hjh.0000000000003495
Cardiovascular disease risk assessment using a deep-learning-based retinal biomarker: a comparison with existing risk scores.
Yi, J. K., Rim, T. H., Park, S., Kim, S. S., Kim, H. C., Lee, C. J., . . . Cheng, C. -Y. (2023). Cardiovascular disease risk assessment using a deep-learning-based retinal biomarker: a comparison with existing risk scores.. European heart journal. Digital health, 4(3), 236-244. doi:10.1093/ehjdh/ztad023
Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis
Proietti, R., Rivera-Caravaca, J. M., Lopez-Galvez, R., Harrison, S. L., Buckley, B. J. R., Marin, F., . . . Lip, G. Y. H. (2023). Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis. CLINICAL CARDIOLOGY, 46(6), 656-662. doi:10.1002/clc.24006
Community echocardiographic left ventricular hypertrophy and mortality in South Asians in the UK: E-ECHOES study
Shantsila, E., Shantsila, A., Williams, N., Lip, G. Y. H., & Gill, P. S. (2023). Community echocardiographic left ventricular hypertrophy and mortality in South Asians in the UK: E-ECHOES study. European Journal of Preventive Cardiology, 30(Supplement_1). doi:10.1093/eurjpc/zwad125.219
Stricter blood pressure control reduces rate of left ventricular hypertrophy and diastolic dysfunction in ethnic minority groups in the UK:E-ECHOES study
Shantsila, A., Shantsila, E., Lip, G. Y. H., & Gill, P. S. (2023). Stricter blood pressure control reduces rate of left ventricular hypertrophy and diastolic dysfunction in ethnic minority groups in the UK:E-ECHOES study. European Journal of Preventive Cardiology, 30(Supplement_1). doi:10.1093/eurjpc/zwad125.207
Pharmacotherapy for hypertension in very old people with frailty: A systematic review
Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis
Proietti, R., Rivera-Caravaza, J. M., Lopez-Galvez, R., Harrison, S. L., Marin, F., Underhill, P., . . . Lip, G. (n.d.). Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis. Journal of Clinical Medicine, 12(8). doi:10.3390/jcm12082814
Altered cardiac and vascular stiffness in pregnancy after a hypertensive pregnancy
Castleman, J. S., Shantsila, A., Brown, R. A., Shantsila, E., & Lip, G. Y. H. (2023). Altered cardiac and vascular stiffness in pregnancy after a hypertensive pregnancy. JOURNAL OF HUMAN HYPERTENSION, 37(3), 189-196. doi:10.1038/s41371-022-00662-4
Validation of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from UK Biobank
Tseng, R. M. W. W., Rim, T. H., Shantsila, E., Yi, J. K., Park, S., Kim, S. S., . . . Cheng, C. -Y. (2023). Validation of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from UK Biobank. In BMC MEDICINE Vol. 21. doi:10.1186/s12916-022-02684-8
Dynamic changes of monocytes subsets predict major adverse cardiovascular events and left ventricular function after STEMI.
Boidin, M., Lip, G. Y. H., Shantsila, A., Thijssen, D., & Shantsila, E. (2023). Dynamic changes of monocytes subsets predict major adverse cardiovascular events and left ventricular function after STEMI.. Scientific reports, 13(1), 48. doi:10.1038/s41598-022-26688-9
2022
Abstract 10113: Validation of a Deep-Learning-Based Retinal Biomarker in the Prediction of Cardiovascular Disease: Data From UK Biobank
Tseng, R. M., Rim, T. H., Shantsila, E., Park, S. H., Kim, S. S., Lee, C. J., . . . Cheng, C. -Y. (2022). Abstract 10113: Validation of a Deep-Learning-Based Retinal Biomarker in the Prediction of Cardiovascular Disease: Data From UK Biobank. Circulation, 146(Suppl_1). doi:10.1161/circ.146.suppl_1.10113
Stroke risk stratification in patients with heart failure and sinus rhythm
Sagris, D., Shantsila, E., & Lip, G. Y. H. (2022). Stroke risk stratification in patients with heart failure and sinus rhythm. EUROPEAN HEART JOURNAL, 43(42), 4480-4482. doi:10.1093/eurheartj/ehac493
Arterial stiffness and atrial fibrillation: shared mechanisms, clinical implications and therapeutic options.
Vio, R., Giordani, A. S., Stefil, M., Madine, J., Fairbairn, T., Themistoclakis, S., . . . Proietti, R. (2022). Arterial stiffness and atrial fibrillation: shared mechanisms, clinical implications and therapeutic options.. Journal of hypertension, 40(9), 1639-1646. doi:10.1097/hjh.0000000000003223
Antiplatelet agents and anticoagulants for hypertension.
Shantsila, E., Kozieł-Siołkowska, M., & Lip, G. Y. (2022). Antiplatelet agents and anticoagulants for hypertension.. The Cochrane database of systematic reviews, 7, CD003186. doi:10.1002/14651858.cd003186.pub4
Monocytes are increased in pregnancy after gestational hypertensive disease
Castleman, J. S., Lip, G. Y. H., & Shantsila, E. (2022). Monocytes are increased in pregnancy after gestational hypertensive disease. SCIENTIFIC REPORTS, 12(1). doi:10.1038/s41598-022-13606-2
Cardiovascular Disorders
Shantsila, E., Shantsila, A., Dzeshka, M. S., & Lip, G. Y. H. (2022). Cardiovascular Disorders. In Textbook of Occupational Medicine Practice (pp. 463-504). WORLD SCIENTIFIC. doi:10.1142/9789811245657_0012
Effect of blood pressure on exercise tolerance in atrial fibrillation: insight from the IMPRESS-AF trial
Shantsila, E., Shantsila, A., & Lip, G. Y. H. (2022). Effect of blood pressure on exercise tolerance in atrial fibrillation: insight from the IMPRESS-AF trial. In JOURNAL OF HUMAN HYPERTENSION Vol. 36 (pp. 19-20). Retrieved from https://www.webofscience.com/
Polypharmacy in Older People With Heart Failure: Roles of the Geriatrician and Pharmacist.
Stefil, M., Dixon, M., Bahar, J., Saied, S., Mashida, K., Heron, O., . . . Sankaranarayanan, R. (2022). Polypharmacy in Older People With Heart Failure: Roles of the Geriatrician and Pharmacist.. Cardiac failure review, 8, e34. doi:10.15420/cfr.2022.14
The DynAIRx Project Protocol: Artificial Intelligence for dynamic prescribing optimisation and care integration in multimorbidity.
Walker, L. E., Abuzour, A. S., Bollegala, D., Clegg, A., Gabbay, M., Griffiths, A., . . . Buchan, I. (2022). The DynAIRx Project Protocol: Artificial Intelligence for dynamic prescribing optimisation and care integration in multimorbidity.. Journal of multimorbidity and comorbidity, 12, 26335565221145493. doi:10.1177/26335565221145493
2021
Abstract 9416: Monocyte Subsets and Exercise Capacity in Patients With Atrial Fibrillation With Preserved Left Ventricular Function
Shahid, F., Lip, G., & Shantsila, E. (2021). Abstract 9416: Monocyte Subsets and Exercise Capacity in Patients With Atrial Fibrillation With Preserved Left Ventricular Function. Circulation, 144(Suppl_1). doi:10.1161/circ.144.suppl_1.9416
Revisiting the diagnosis of 'resistant hypertension': what should we do nowadays'
Alsharari, R., Shantsila, E., Lip, G. Y. H., & Shantsila, A. (2021). Revisiting the diagnosis of 'resistant hypertension': what should we do nowadays'. JOURNAL OF HUMAN HYPERTENSION. doi:10.1038/s41371-021-00631-3
Heart Failure With Sinus Rhythm: Does Anticoagulation Reduce Stroke at All?
Zhang, J., Shantsila, E., & Lip, G. Y. H. (2021). Heart Failure With Sinus Rhythm: Does Anticoagulation Reduce Stroke at All?. JOURNAL OF CARDIAC FAILURE, 27(8), 865-868. doi:10.1016/j.cardfail.2021.03.008
Anticoagulation versus placebo for heart failure in sinus rhythm
Shantsila, E., Koziel, M., & Lip, G. Y. H. (2021). Anticoagulation versus placebo for heart failure in sinus rhythm. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD003336.pub4
Effects of antithrombotic drugs on the prothrombotic state in patients with atrial fibrillation: The west Birmingham atrial fibrillation project
Voukalis, C., Lip, G. Y. H., & Shantsila, E. (2021). Effects of antithrombotic drugs on the prothrombotic state in patients with atrial fibrillation: The west Birmingham atrial fibrillation project. THROMBOSIS RESEARCH, 200, 149-155. doi:10.1016/j.thromres.2021.02.005
Hypertension and sleep health: a multidimensional puzzle
Shantsila, A., Shantsila, E., & Lip, G. Y. H. (2021). Hypertension and sleep health: a multidimensional puzzle. JOURNAL OF HYPERTENSION, 39(4), 600-601. doi:10.1097/HJH.0000000000002743
Monocyte Subsets and Exercise Capacity in Patients With Atrial Fibrillation With Preserved Left Ventricular Function
Shahid, F., Lip, G., & Shantsila, E. (2021). Monocyte Subsets and Exercise Capacity in Patients With Atrial Fibrillation With Preserved Left Ventricular Function. In CIRCULATION Vol. 144. Retrieved from https://www.webofscience.com/
Observations on clot properties in atrial fibrillation: Relation to renal function and choice of anticoagulant
Khan, A. A., Hardy, L. J., Shantsila, E., Lau, Y. C., Philippou, H., & Lip, G. Y. H. (2021). Observations on clot properties in atrial fibrillation: Relation to renal function and choice of anticoagulant. THROMBOSIS RESEARCH, 197, 69-76. doi:10.1016/j.thromres.2020.10.039
2020
Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS-AF Trial
Shantsila, E., Shahid, F., Sun, Y., Deeks, J., Calvert, M., Fisher, J. P., . . . Lip, G. Y. H. (2020). Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS-AF Trial. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 9(18). doi:10.1161/JAHA.119.016239
Blood pressure targets in atrial fibrillation.
Shantsila, A., Shantsila, E., & Lip, G. Y. H. (2020). Blood pressure targets in atrial fibrillation.. European heart journal, 41(30), 2860-2862. doi:10.1093/eurheartj/ehaa319
Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation
Begg, G. A., Swoboda, P. P., Karim, R., Oesterlein, T., Rhode, K., Holden, A. V., . . . Tayebjee, M. H. (2020). Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation. JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 22(1). doi:10.1186/s12968-020-0603-y
Spironolactone to improve exercise tolerance in people with permanent atrial fibrillation and preserved ejection fraction: the IMPRESS-AF RCT
Shantsila, E., Shahid, F., Sun, Y., Deeks, J. J., Haynes, R., Calvert, M., . . . Lip, G. Y. H. (2020). Spironolactone to improve exercise tolerance in people with permanent atrial fibrillation and preserved ejection fraction: the IMPRESS-AF RCT.
2019
Guideline-Adherent Treatment for Stroke and Death in Atrial Fibrillation Patients From UK and Japanese AF Registries.
Miyazawa, K., Ogawa, H., Mazurek, M., Shantsila, E., Lane, D. A., Wolff, A., . . . Lip, G. Y. H. (2019). Guideline-Adherent Treatment for Stroke and Death in Atrial Fibrillation Patients From UK and Japanese AF Registries.. Circulation journal : official journal of the Japanese Circulation Society, 83(12), 2434-2442. doi:10.1253/circj.cj-19-0546
Microparticles and cardiovascular diseases
Voukalis, C., Shantsila, E., & Lip, G. Y. H. (2019). Microparticles and cardiovascular diseases. ANNALS OF MEDICINE, 51(3-4), 193-223. doi:10.1080/07853890.2019.1609076
COMPARISON OF VARIOUS ANTICOAGULANTS ON CLOT STRUCTURE IN ATRIAL FIBRILLATION
Khan, A., Shantsila, E., Lau, Y. C., Hardy, L., Philippou, H., & Lip, G. (2019). COMPARISON OF VARIOUS ANTICOAGULANTS ON CLOT STRUCTURE IN ATRIAL FIBRILLATION. In HEART Vol. 105 (pp. A153). doi:10.1136/heartjnl-2019-BCS.183
DOES CHANGE IN RENAL FUNCTION AFFECT WARFARIN'S EFFICACY IN PATIENTS WITH ATRIAL FIBRILLATION?
Khan, A., Shantsila, E., Lau, Y. C., Hardy, L., Philippou, H., & Lip, G. (2019). DOES CHANGE IN RENAL FUNCTION AFFECT WARFARIN'S EFFICACY IN PATIENTS WITH ATRIAL FIBRILLATION?. In HEART Vol. 105 (pp. A176-A177). doi:10.1136/heartjnl-2019-BCS.218
HOW WARFARIN AND ANTIPLATELETS AFFECT CLOT STRUCTURE IN ATRIAL FIBRILLATION
Khan, A., Shantsila, E., Lau, Y. C., Hardy, L., Philippou, H., & Lip, G. (2019). HOW WARFARIN AND ANTIPLATELETS AFFECT CLOT STRUCTURE IN ATRIAL FIBRILLATION. In HEART Vol. 105 (pp. A166-A167). doi:10.1136/heartjnl-2019-BCS.204
Mon2 predicts poor outcome in ST-elevation myocardial infarction
Shantsila, E., Ghattas, A., Griffiths, H. R., & Lip, G. Y. H. (2019). Mon2 predicts poor outcome in ST-elevation myocardial infarction. JOURNAL OF INTERNAL MEDICINE, 285(3), 301-316. doi:10.1111/joim.12847
Circulating biomarkers of myocardial fibrosis and cellular apoptosis in patients with atrial fibrillation and heart failure with preserved ejection fraction
Dzeshka, M. S., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2019). Circulating biomarkers of myocardial fibrosis and cellular apoptosis in patients with atrial fibrillation and heart failure with preserved ejection fraction. In EUROPEAN HEART JOURNAL Vol. 40 (pp. 2381). Retrieved from https://www.webofscience.com/
Relation of atrial remodeling to circulating biomarkers of myocardial fibrosis and apoptotic microparticles in patients with atrial fibrillation and heart failure with preserved ejection fraction
Dzeshka, M. S., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2019). Relation of atrial remodeling to circulating biomarkers of myocardial fibrosis and apoptotic microparticles in patients with atrial fibrillation and heart failure with preserved ejection fraction. In EUROPEAN HEART JOURNAL Vol. 40 (pp. 1852). Retrieved from https://www.webofscience.com/
2018
Heart Failure and Stroke.
Schumacher, K., Kornej, J., Shantsila, E., & Lip, G. Y. H. (2018). Heart Failure and Stroke.. Current heart failure reports, 15(5), 287-296. doi:10.1007/s11897-018-0405-9
Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation
Borgognone, A., Shantsila, E., Worrall, S. M., Prompunt, E., Loka, T., Loudon, B. L., . . . Madhani, M. (2018). Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation. CARDIOVASCULAR RESEARCH, 114(10), 1313-1323. doi:10.1093/cvr/cvy087
Predictors of diastolic dysfunction in ethnic groups: observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES)
Shantsila, A., Shantsila, E., Gill, P. S., & Lip, G. Y. H. (2018). Predictors of diastolic dysfunction in ethnic groups: observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES). JOURNAL OF HUMAN HYPERTENSION, 32(7), 477-486. doi:10.1038/s41371-018-0064-z
Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project
Shahid, F., Rahmat, N. A., Lip, G. Y. H., & Shantsila, E. (2018). Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project. PLOS ONE, 13(7). doi:10.1371/journal.pone.0200373
HIGH HEART RATE PREDICTS CARDIAC FIBROSIS IN PATIENTS WITH ATRIAL FIBRILLATION AND PRESERVED LEFT VENTRICULAR FUNCTION
Shahid, F., Lip, G., & Shantsila, E. (2018). HIGH HEART RATE PREDICTS CARDIAC FIBROSIS IN PATIENTS WITH ATRIAL FIBRILLATION AND PRESERVED LEFT VENTRICULAR FUNCTION. In HEART Vol. 104 (pp. A76-A77). doi:10.1136/heartjnl-2018-BCS.91
TOTAL MONOCYTE COUNT AS PREDICTOR OF EXERCISE CAPACITY IN PATIENTS WITH PERMANENT ATRIAL FIBRILLATION AND PRESERVED LEFT VENTRICULAR FUNCTION - THE WEST BIRMINGHAM AF PROJECT
Khan, A., Shahid, F., Lip, G., & Shantsila, E. (2018). TOTAL MONOCYTE COUNT AS PREDICTOR OF EXERCISE CAPACITY IN PATIENTS WITH PERMANENT ATRIAL FIBRILLATION AND PRESERVED LEFT VENTRICULAR FUNCTION - THE WEST BIRMINGHAM AF PROJECT. In HEART Vol. 104 (pp. A79). doi:10.1136/heartjnl-2018-BCS.96
Impact of Mon2 monocyte-platelet aggregates on human coronary artery disease
Brown, R. A., Lip, G. Y. H., Varma, C., & Shantsila, E. (2018). Impact of Mon2 monocyte-platelet aggregates on human coronary artery disease. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 48(5). doi:10.1111/eci.12911
Role of Monocytes in Heart Failure and Atrial Fibrillation
Shahid, F., Lip, G. Y. H., & Shantsila, E. (2018). Role of Monocytes in Heart Failure and Atrial Fibrillation. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 7(3). doi:10.1161/JAHA.117.007849
Association of circulating apoptotic (annexin V plus ) microparticles with ventricular fibrosis and diastolic dysfunction in atrial fibrillation patients with heart failure with preserved ejection fraction
Dzeshka, M. S., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2018). Association of circulating apoptotic (annexin V plus ) microparticles with ventricular fibrosis and diastolic dysfunction in atrial fibrillation patients with heart failure with preserved ejection fraction. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 612). Retrieved from https://www.webofscience.com/
CHA2DS2VASc score predicts exercise capacity in patients with permanent atrial fibrillation and preserved left ventricular function
Khan, A., Shahid, F., Lip, G. Y. H., & Shantsila, E. (2018). CHA2DS2VASc score predicts exercise capacity in patients with permanent atrial fibrillation and preserved left ventricular function. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 402). Retrieved from https://www.webofscience.com/
Circulating monocyte-derived (CD14+) and apoptotic (annexin V-binding) microparticles correlate with recurrent atrial fibrillation
Dzeshka, M. S., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2018). Circulating monocyte-derived (CD14+) and apoptotic (annexin V-binding) microparticles correlate with recurrent atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 412-413). Retrieved from https://www.webofscience.com/
Galectin 3 as a marker of diastolic dysfunction in patients with atrial fibrillation and heart failure with preserved ejection fraction
Dzeshka, M. S., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2018). Galectin 3 as a marker of diastolic dysfunction in patients with atrial fibrillation and heart failure with preserved ejection fraction. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1387). Retrieved from https://www.webofscience.com/
MONOCYTE SUBPOPULATIONS IN PATIENTS FOLLOWING ST-ELEVATION MYOCARDIAL INFARCTION: IMPLICATIONS FOR POST-INFARCTION LEFT VENTRICULAR REMODELLING AND CLINICAL OUTCOMES
Ghattas, A., Shantsila, E., Griffiths, H., & Lip, G. (2018). MONOCYTE SUBPOPULATIONS IN PATIENTS FOLLOWING ST-ELEVATION MYOCARDIAL INFARCTION: IMPLICATIONS FOR POST-INFARCTION LEFT VENTRICULAR REMODELLING AND CLINICAL OUTCOMES. In HEART Vol. 104 (pp. A4). doi:10.1136/heartjnl-2018-BCIS.7
Predictors of exercise capacity in the elderly population with permanent atrial fibrillation and preserved left ventricular function
Khan, A. A., Shahid, F., Lip, G. Y. H., & Shantsila, E. (2018). Predictors of exercise capacity in the elderly population with permanent atrial fibrillation and preserved left ventricular function. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 95). Retrieved from https://www.webofscience.com/
Risk Stratification in Atrial Fibrillation
Shahid, F., Dzeshka, M., Shantsila, E., & Lip, G. Y. H. (2019). Risk Stratification in Atrial Fibrillation. In Stroke Prevention in Atrial Fibrillation (pp. 47-66). Elsevier. doi:10.1016/b978-0-323-55429-9.00004-2
Self-reported physical activity is associated with biomarkers of cardiac fibrosis and cell apoptosis in patients with atrial fibrillation
Dzeshka, M. S., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2018). Self-reported physical activity is associated with biomarkers of cardiac fibrosis and cell apoptosis in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 611). Retrieved from https://www.webofscience.com/
2017
Atrial Fibrillation and Hypertension
Dzeshka, M. S., Shantsila, A., Shantsila, E., & Lip, G. Y. H. (2017). Atrial Fibrillation and Hypertension. HYPERTENSION, 70(5), 854-+. doi:10.1161/HYPERTENSIONAHA.117.08934
Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry
Shantsila, A., Shantsila, E., Beevers, D. G., & Lip, G. Y. H. (2017). Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry. JOURNAL OF HYPERTENSION, 35(11), 2310-2314. doi:10.1097/HJH.0000000000001446
Is echocardiography valid and reproducible in patients with atrial fibrillation? A systematic review
Kotecha, D., Mohamed, M., Shantsila, E., Popescu, B. A., & Steeds, R. P. (2017). Is echocardiography valid and reproducible in patients with atrial fibrillation? A systematic review. EUROPACE, 19(9), 1427-1438. doi:10.1093/europace/eux027
Guideline-Adherent Antithrombotic Treatment Improves Outcomes in Patients With Atrial Fibrillation: Insights From the Community-Based Darlington Atrial Fibrillation Registry
Mazurek, M., Shantsila, E., Lane, D. A., Wolff, A., Proietti, M., & Lip, G. Y. H. (2017). Guideline-Adherent Antithrombotic Treatment Improves Outcomes in Patients With Atrial Fibrillation: Insights From the Community-Based Darlington Atrial Fibrillation Registry. MAYO CLINIC PROCEEDINGS, 92(8), 1203-1213. doi:10.1016/j.mayocp.2017.05.023
Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry
Mazurek, M., Shantsila, E., Lane, D. A., Wolff, A., Proietti, M., & Lip, G. Y. H. (2017). Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry. STROKE, 48(8), 2198-2205. doi:10.1161/STROKEAHA.116.016146
Renin-angiotensin blockade in atrial fibrillation: where are we now?
Shahid, F., Lip, G. Y. H., & Shantsila, E. (2017). Renin-angiotensin blockade in atrial fibrillation: where are we now?. JOURNAL OF HUMAN HYPERTENSION, 31(7), 425-426. doi:10.1038/jhh.2017.6
Microvesicles in vascular homeostasis and diseases Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology
Ridger, V. C., Boulanger, C. M., Angelillo-Scherrer, A., Badimon, L., Blanc-Brude, O., Bochaton-Piallat, M. -L., . . . Harrison, P. (2017). Microvesicles in vascular homeostasis and diseases Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology. THROMBOSIS AND HAEMOSTASIS, 117(7), 1296-1316. doi:10.1160/TH16-12-0943
Clinical Features and Prognosis in Patients with Atrial Fibrillation and Prior Stroke: Comparing the Fushimi and Darlington AF Registries
Ogawa, H., Senoo, K., An, Y., Shantsila, A., Shantsila, E., Lane, D. A., . . . Lip, G. Y. H. (2017). Clinical Features and Prognosis in Patients with Atrial Fibrillation and Prior Stroke: Comparing the Fushimi and Darlington AF Registries. EBIOMEDICINE, 18, 199-203. doi:10.1016/j.ebiom.2017.03.022
Current Understanding of Atherogenesis
Brown, R. A., Shantsila, E., Varma, C., & Lip, G. Y. H. (2017). Current Understanding of Atherogenesis. AMERICAN JOURNAL OF MEDICINE, 130(3), 268-282. doi:10.1016/j.amjmed.2016.10.022
Renal dysfunction and diastolic impairment among British ethnic minorities with hypertension: the Ethnic-Echocardiographic Heart of England Screening Study
Shantsila, A., Shantsila, E., Gill, P. S., & Lip, G. Y. H. (2017). Renal dysfunction and diastolic impairment among British ethnic minorities with hypertension: the Ethnic-Echocardiographic Heart of England Screening Study. JOURNAL OF HUMAN HYPERTENSION, 31(3), 206-211. doi:10.1038/jhh.2016.68
Reply
Voukalis, C., Shantsila, E., & Lip, G. Y. H. (2017). Reply. Journal of the Royal College of Physicians of Edinburgh, 47(2), 205-206. doi:10.1177/1478271520174702003
Atherothrombotic strokes in NVAF Reply
Voukalis, C., Shantsila, E., & Lip, G. Y. H. (2017). Atherothrombotic strokes in NVAF Reply. JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 47(2), 205-206. Retrieved from https://www.webofscience.com/
Increased evidence of left ventricular myocardial fibrosis in patients with paroxysmal atrial fibrillation and sinus node dysfunction
Dzeshka, M. S., Appadoo, K., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2017). Increased evidence of left ventricular myocardial fibrosis in patients with paroxysmal atrial fibrillation and sinus node dysfunction. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 379). Retrieved from https://www.webofscience.com/
Monocyte counts predict major bleeding events in patients with atrial fibrillation
Shahid, F., Lip, G. Y. H., Montoro-Garcia, S., Rahmat, A., & Shantsila, E. (2017). Monocyte counts predict major bleeding events in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 779-780). Retrieved from https://www.webofscience.com/
Monocyte subsets in cardiac disease and repair
Shantsila, E. (2017). Monocyte subsets in cardiac disease and repair. In ACTA PHYSIOLOGICA Vol. 221 (pp. 52). Retrieved from https://www.webofscience.com/
Stroke prevention in atrial fibrillation
Voukalis, C., Shantsila, E., & Lip, G. Y. H. (2017). Stroke prevention in atrial fibrillation. JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 47(1), 13-23. doi:10.4997/JRCPE.2017.105
2016
What do the guidelines suggest for non-vitamin K antagonist oral anticoagulant use for stroke prevention in atrial fibrillation?
Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016). What do the guidelines suggest for non-vitamin K antagonist oral anticoagulant use for stroke prevention in atrial fibrillation?. EUROPEAN HEART JOURNAL SUPPLEMENTS, 18(I), 18-24. doi:10.1093/eurheartj/suw049
Chronic Osteomyelitis and Atrial Fibrillation: Revisiting the Link Between Inflammation Burden and Arrhythmia
Shahid, F., Lip, G. Y. H., & Shantsila, E. (2016). Chronic Osteomyelitis and Atrial Fibrillation: Revisiting the Link Between Inflammation Burden and Arrhythmia. CANADIAN JOURNAL OF CARDIOLOGY, 32(12), 1366-1368. doi:10.1016/j.cjca.2016.05.002
Drug-drug interactions of non-vitamin K oral anticoagulants
Voukalis, C., Lip, G. Y. H., & Shantsila, E. (2016). Drug-drug interactions of non-vitamin K oral anticoagulants. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 12(12), 1445-1461. doi:10.1080/17425255.2016.1225037
Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom
Senoo, K., An, Y., Ogawa, H., Lane, D. A., Wolff, A., Shantsila, E., . . . Lip, G. Y. H. (2016). Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom. HEART, 102(23), 1878-1882. doi:10.1136/heartjnl-2016-309741
Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation
Lau, Y. C., Xiong, Q., Shantsila, E., Lip, G. Y. H., & Blann, A. D. (2016). Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 42(4), 535-544. doi:10.1007/s11239-016-1399-3
Premature Cardiac Aging in South Asian Compared to Afro-Caribbean Subjects in a Community-Based Screening Study
Shantsila, E., Shantsila, A., Gill, P. S., & Lip, G. Y. H. (2016). Premature Cardiac Aging in South Asian Compared to Afro-Caribbean Subjects in a Community-Based Screening Study. Journal of the American Heart Association, 5(11). doi:10.1161/JAHA.116.004110
Non-vitamin K oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolic disease
Voukalis, C., Lip, G. Y. H., & Shantsila, E. (2016). Non-vitamin K oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolic disease. EXPERT OPINION ON PHARMACOTHERAPY, 17(15), 2033-2047. doi:10.1080/14656566.2016.1232393
IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial
Shantsila, E., Haynes, R., Calvert, M., Fisher, J., Kirchhof, P., Gill, P. S., & Lip, G. Y. H. (2016). IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial. BMJ OPEN, 6(10). doi:10.1136/bmjopen-2016-012241
Role and analysis of monocyte subsets in cardiovascular disease Joint consensus document of the European Society of Cardiology (ESC) Working Groups "Atherosclerosis & Vascular Biology" and "Thrombosis"
Weber, C., Shantsila, E., Hristov, M., Caligiuri, G., Guzik, T., Heine, G. H., . . . Lip, G. Y. H. (2016). Role and analysis of monocyte subsets in cardiovascular disease Joint consensus document of the European Society of Cardiology (ESC) Working Groups "Atherosclerosis & Vascular Biology" and "Thrombosis". THROMBOSIS AND HAEMOSTASIS, 116(4), 626-637. doi:10.1160/TH16-02-0091
Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm
Shantsila, E., & Lip, G. Y. H. (2016). Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (9). doi:10.1002/14651858.CD003333.pub3
Use of non-vitamin K antagonist oral anticoagulants in patients with heart failure and atrial fibrillation: does concomitant kidney disease change our practice?
Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016). Use of non-vitamin K antagonist oral anticoagulants in patients with heart failure and atrial fibrillation: does concomitant kidney disease change our practice?. EUROPEAN JOURNAL OF HEART FAILURE, 18(9), 1172-1174. doi:10.1002/ejhf.552
Epidemiology and pathogenesis of diffuse obstructive coronary artery disease: the role of arterial stiffness, shear stress, monocyte subsets and circulating microparticles
Brown, R. A., Shantsila, E., Varma, C., & Lip, G. Y. H. (2016). Epidemiology and pathogenesis of diffuse obstructive coronary artery disease: the role of arterial stiffness, shear stress, monocyte subsets and circulating microparticles. ANNALS OF MEDICINE, 48(6), 444-455. doi:10.1080/07853890.2016.1190861
Atrial fibrillation and its complications: a focus on identifying risk factors and risk stratification
Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016). Atrial fibrillation and its complications: a focus on identifying risk factors and risk stratification. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2(2), 88-+. doi:10.1093/ehjcvp/pvv057
Treatment of Atrial Fibrillation in Patients With Chronic Kidney Disease Is Stroke Prevention Worth the Risk?
Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016). Treatment of Atrial Fibrillation in Patients With Chronic Kidney Disease Is Stroke Prevention Worth the Risk?. CHEST, 149(4), 891-892. doi:10.1016/j.chest.2015.09.026
Symptom-to-door times in patients presenting with ST elevation myocardial infarction-do ethnic or gender differences exist?
Brown, R. A., Shantsila, E., Varma, C., & Lip, G. Y. H. (2016). Symptom-to-door times in patients presenting with ST elevation myocardial infarction-do ethnic or gender differences exist?. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 109(3), 175-180. doi:10.1093/qjmed/hcv112
Emerging Tools for Stroke Prevention in Atrial Fibrillation
Voukalis, C., Lip, G. Y. H., & Shantsila, E. (2016). Emerging Tools for Stroke Prevention in Atrial Fibrillation. EBIOMEDICINE, 4, 26-39. doi:10.1016/j.ebiom.2016.01.017
Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction?
Shantsila, E., & Lip, G. Y. H. (2016). Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction?. EBIOMEDICINE, 4, 5-6. doi:10.1016/j.ebiom.2016.01.025
Characteristics and outcomes in elderly Japanese and British patients with atrial fibrillation: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries
Ogawa, H., Senoo, K., An, Y., Shantsila, A., Shantsila, E., Lane, D. A., . . . Lip, G. Y. H. (2016). Characteristics and outcomes in elderly Japanese and British patients with atrial fibrillation: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1345). Retrieved from https://www.webofscience.com/
Deprivation and prediction of heart failure in minority ethnic patients: the Ethnic - Echocardiographic Heart of England Screening Study (E-ECHOES)
Shantsila, A., Shantsila, E., Gill, P. S., & Lip, G. Y. H. (2016). Deprivation and prediction of heart failure in minority ethnic patients: the Ethnic - Echocardiographic Heart of England Screening Study (E-ECHOES). In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1108). Retrieved from https://www.webofscience.com/
Ethnic disparities between Japanese and British atrial fibrillation patients with previous stroke: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries
Ogawa, H., Senoo, K., An, Y., Shantsila, A., Shantsila, E., Lane, D. A., . . . Lip, G. Y. H. (2016). Ethnic disparities between Japanese and British atrial fibrillation patients with previous stroke: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1137-1138). Retrieved from https://www.webofscience.com/
Guideline-adherent antithrombotic treatment improves outcomes in patients with atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry
Mazurek, M., Shantsila, E., Lane, D., Wolff, A., Proietti, M., & Lip, G. Y. (2016). Guideline-adherent antithrombotic treatment improves outcomes in patients with atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1348). Retrieved from https://www.webofscience.com/
Inflammation and myocardial stiffness in hypertension: observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES)
Shantsila, A., Shantsila, E., Gill, P. S., & Lip, G. Y. H. (2016). Inflammation and myocardial stiffness in hypertension: observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES). In JOURNAL OF HUMAN HYPERTENSION Vol. 30 (pp. 648). Retrieved from https://www.webofscience.com/
Is echocardiography valid and reproducible in patients with atrial fibrillation? a systematic review
Mohamed, M. O., Shantsila, E., Steeds, R., Popescu, B. A., & Kotecha, D. (2016). Is echocardiography valid and reproducible in patients with atrial fibrillation? a systematic review. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 286). Retrieved from https://www.webofscience.com/
Monocyte-platelet aggregates associated with CD14++CD16+monocytes predict diffuse coronary artery disease: relationship to microvascular function
Brown, R. A., Lip, G. Y. H., Varma, C., & Shantsila, E. (2016). Monocyte-platelet aggregates associated with CD14++CD16+monocytes predict diffuse coronary artery disease: relationship to microvascular function. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 812). Retrieved from https://www.webofscience.com/
Premature cardiac ageing in South Asians: the ethnic-echocardiographic heart of England screening study (E-ECHOES)
Shantsila, E., Shantsila, A., Gill, P. S., & Lip, G. Y. H. (2016). Premature cardiac ageing in South Asians: the ethnic-echocardiographic heart of England screening study (E-ECHOES). In EUROPEAN HEART JOURNAL Vol. 37 (pp. 931). Retrieved from https://www.webofscience.com/
Preventing Thrombosis to Improve Outcomes in Heart Failure Patients
Shantsila, E., & Lip, G. Y. H. (2016). Preventing Thrombosis to Improve Outcomes in Heart Failure Patients. PROGRESS IN CARDIOVASCULAR DISEASES, 58(4), 386-392. doi:10.1016/j.pcad.2015.09.005
Recent advances in the understanding and management of atrial fibrillation: a focus on stroke prevention.
Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016). Recent advances in the understanding and management of atrial fibrillation: a focus on stroke prevention.. F1000Research, 5, 2887. doi:10.12688/f1000research.10176.1
Secondary versus primary stroke prevention in atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry
Mazurek, M., Shantsila, E., Lane, D., Wolff, A., Proietti, M., & Lip, G. Y. (2016). Secondary versus primary stroke prevention in atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 845). Retrieved from https://www.webofscience.com/
2015
CD4<SUP>+</SUP> T cell surface alpha enolase is lower in older adults
Bennett, S. J., Augustyniak, E. M., Dunston, C. R., Brown, R. A., Shantsila, E., Lip, G. Y. H., . . . Griffiths, H. R. (2015). CD4<SUP>+</SUP> T cell surface alpha enolase is lower in older adults. MECHANISMS OF AGEING AND DEVELOPMENT, 152, 56-62. doi:10.1016/j.mad.2015.09.005
Safety and efficacy of abciximab in older adults undergoing percutaneous coronary intervention
Brown, R. A., Shantsila, E., Varma, C., & Lip, G. Y. H. (2015). Safety and efficacy of abciximab in older adults undergoing percutaneous coronary intervention. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 69(11), 1334-1340. doi:10.1111/ijcp.12702
Small-size Microparticles as Indicators of Acute Decompensated State in Ischemic Heart Failure
Montoro-Garcia, S., Shantsila, E., Wrigley, B. J., Tapp, L. D., Abellan Aleman, J., & Lip, G. Y. H. (2015). Small-size Microparticles as Indicators of Acute Decompensated State in Ischemic Heart Failure. REVISTA ESPANOLA DE CARDIOLOGIA, 68(11), 951-958. doi:10.1016/j.rec.2014.11.016
Stroke in atrial fibrillation and improving the identification of 'high-risk' patients: the crossroads of immunity and thrombosis
Shantsila, E., & Lip, G. Y. H. (2015). Stroke in atrial fibrillation and improving the identification of 'high-risk' patients: the crossroads of immunity and thrombosis. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 13(11), 1968-1970. doi:10.1111/jth.13121
Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice
Wolff, A., Shantsila, E., Lip, G. Y. H., & Lane, D. A. (2015). Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice. AGE AND AGEING, 44(5), 874-878. doi:10.1093/ageing/afv071
Cardiac Fibrosis in Patients With Atrial Fibrillation Mechanisms and Clinical Implications
Dzeshka, M. S., Lip, G. Y. H., Snezhitskiy, V., & Shantsila, E. (2015). Cardiac Fibrosis in Patients With Atrial Fibrillation Mechanisms and Clinical Implications. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 66(8), 943-959. doi:10.1016/j.jacc.2015.06.1313
Ethnic differences in the diurnal variation of symptom onset time for acute ST elevation myocardial infarction - An observational cohort study
Brown, R. A., Lip, G. Y. H., Varma, C., & Shantsila, E. (2015). Ethnic differences in the diurnal variation of symptom onset time for acute ST elevation myocardial infarction - An observational cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 187, 414-416. doi:10.1016/j.ijcard.2015.03.371
Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool
Shantsila, E., Wolff, A., Lip, G. Y. H., & Lane, D. A. (2015). Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 69(8), 840-845. doi:10.1111/ijcp.12625
CD36 expression and lipid metabolism following an oral glucose challenge in South Asians
Patel, J. V., Banerjee, A., Montoro-Garcia, S., Shantsila, E., Alam, M., Flinders, P., . . . Gill, P. S. (2015). CD36 expression and lipid metabolism following an oral glucose challenge in South Asians. WORLD JOURNAL OF DIABETES, 6(7), 983-989. doi:10.4239/wjd.v6.i7.983
SOUTH ASIAN ETHNICITY IS INDEPENDENTLY RELATED TO DIASTOLIC FUNCTION IN HYPERTENSION
Shantsila, A., Gill, P. S., Shantsila, E., & Lip, G. Y. H. (2015). SOUTH ASIAN ETHNICITY IS INDEPENDENTLY RELATED TO DIASTOLIC FUNCTION IN HYPERTENSION. In HEART Vol. 101 (pp. A71). doi:10.1136/heartjnl-2015-308066.124
Simultaneous computerised activation of the primary percutaneous coronary intervention pathway reduces out-of-hours door-to-balloon time but not mortality
Brown, R. A., Varma, C., Connolly, D. L., Ahmad, R., Shantsila, E., & Lip, G. Y. H. (2015). Simultaneous computerised activation of the primary percutaneous coronary intervention pathway reduces out-of-hours door-to-balloon time but not mortality. INTERNATIONAL JOURNAL OF CARDIOLOGY, 186, 226-230. doi:10.1016/j.ijcard.2015.03.172
Free Light Chains in patients with acute coronary syndromes: Relationships to inflammation and renal function
Shantsila, E., Tapp, L. D., & Lip, G. Y. H. (2015). Free Light Chains in patients with acute coronary syndromes: Relationships to inflammation and renal function. INTERNATIONAL JOURNAL OF CARDIOLOGY, 185, 322-327. doi:10.1016/j.ijcard.2015.03.105
Optimising stroke prevention in patients with atrial fibrillation
Lane, D. A., Wolff, A., Shantsila, E., & Lip, G. Y. H. (2015). Optimising stroke prevention in patients with atrial fibrillation. BRITISH JOURNAL OF GENERAL PRACTICE, 65(632), 117. doi:10.3399/bjgp15X683905
CD14<SUP>+</SUP>+CD16<SUP>+</SUP>CCR2+MONOCYTES ARE INCREASED IN DIFFUSE CORONARY ARTERY DISEASE
Brown, R., Lip, G., Varma, C., & Shantsila, E. (2015). CD14<SUP>+</SUP>+CD16<SUP>+</SUP>CCR2+MONOCYTES ARE INCREASED IN DIFFUSE CORONARY ARTERY DISEASE. In HEART Vol. 101 (pp. A90). Retrieved from https://www.webofscience.com/
Effect of alcohol intake on diastolic function: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES)
Shantsila, E., Shantsila, A., Gill, P. S., & Lip, G. Y. H. (2015). Effect of alcohol intake on diastolic function: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES). In EUROPEAN HEART JOURNAL Vol. 36 (pp. 314-315). Retrieved from https://www.webofscience.com/
Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort
Shantsila, E., Wolff, A., Lip, G. Y. H., & Lane, D. A. (2015). Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort. BRITISH JOURNAL OF GENERAL PRACTICE, 65(630), E16-E23. doi:10.3399/bjgp15X683113
Plasma cell-free DNA levels are elevated in patients with acute ischemic heart failure partially due to neutrophil extracellular trap formation
Brill, A., Shantsila, E., Ponomaryov, T., Dinsdale, R., Harrison, P., & Lip, G. (2015). Plasma cell-free DNA levels are elevated in patients with acute ischemic heart failure partially due to neutrophil extracellular trap formation. In JOURNAL OF THROMBOSIS AND HAEMOSTASIS Vol. 13 (pp. 379-380). Retrieved from https://www.webofscience.com/
Relationship of renal impairment and diastolic dysfunction to hypertension in minority ethnic groups: ethnic-echocardiographic heart of England screening study (E-ECHOES)
Shantsila, A., Gill, P. S., Shantsila, E., & Lip, G. Y. H. (2015). Relationship of renal impairment and diastolic dysfunction to hypertension in minority ethnic groups: ethnic-echocardiographic heart of England screening study (E-ECHOES). In EUROPEAN HEART JOURNAL Vol. 36 (pp. 25). Retrieved from https://www.webofscience.com/
2014
The Heart and Brain Imaging in Lone Atrial Fibrillation - Are We Surprised?
Shantsila, E., Haeusler, K. G., Fiebach, J. B., Breithardt, G., & Kirchhof, P. (2015). The Heart and Brain Imaging in Lone Atrial Fibrillation - Are We Surprised?. CURRENT PHARMACEUTICAL DESIGN, 21(5), 613-621. Retrieved from https://www.webofscience.com/
Expression of monocyte subsets and angiogenic markers in relation to carotid plaque neovascularization in patients with pre-existing coronary artery disease and carotid stenosis
Jaipersad, A. S., Shantsila, A., Lip, G. Y. H., & Shantsila, E. (2014). Expression of monocyte subsets and angiogenic markers in relation to carotid plaque neovascularization in patients with pre-existing coronary artery disease and carotid stenosis. ANNALS OF MEDICINE, 46(7), 530-538. doi:10.3109/07853890.2014.931101
Free Light Chains in Patients With Acute Heart Failure Secondary to Atherosclerotic Coronary Artery Disease
Shantsila, E., Wrigley, B., & Lip, G. Y. H. (2014). Free Light Chains in Patients With Acute Heart Failure Secondary to Atherosclerotic Coronary Artery Disease. AMERICAN JOURNAL OF CARDIOLOGY, 114(8), 1243-1248. doi:10.1016/j.amjcard.2014.07.049
Thrombotic Complications in Heart Failure An Underappreciated Challenge
Shantsila, E., & Lip, G. Y. H. (2014). Thrombotic Complications in Heart Failure An Underappreciated Challenge. CIRCULATION, 130(5), 387-389. doi:10.1161/CIRCULATIONAHA.114.011353
Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin
Montoro-Garcia, S., Shantsila, E., Hernandez-Romero, D., Jover, E., Valdes, M., Marin, F., & Lip, G. Y. H. (2014). Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin. In CARDIOVASCULAR RESEARCH Vol. 103. doi:10.1093/cvr/cvu094.1
ETHNIC AND GENDER DIFFERENCES IN SYMPTOM-TO-DOOR TIMES IN PATIENTS PRESENTING WITH ST ELEVATION MYOCARDIAL INFARCTION
Brown, R., Shantsila, E., Varma, C., & Lip, G. (2014). ETHNIC AND GENDER DIFFERENCES IN SYMPTOM-TO-DOOR TIMES IN PATIENTS PRESENTING WITH ST ELEVATION MYOCARDIAL INFARCTION. In HEART Vol. 100 (pp. A18-A19). doi:10.1136/heartjnl-2014-306118.34
MONOCYTE SUBPOPULATIONS COUNTS AND ASSOCIATIONS WITH GLOBAL LONGITUDINAL STRAIN IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS WITH NORMAL EJECTION FRACTION
Ghattas, A., Shantsila, E., Griffiths, H., & Lip, G. (2014). MONOCYTE SUBPOPULATIONS COUNTS AND ASSOCIATIONS WITH GLOBAL LONGITUDINAL STRAIN IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS WITH NORMAL EJECTION FRACTION. In HEART Vol. 100 (pp. A19-A20). doi:10.1136/heartjnl-2014-306118.36
Anticoagulation versus placebo for heart failure in sinus rhythm
Lip, G. Y. H., & Shantsila, E. (2014). Anticoagulation versus placebo for heart failure in sinus rhythm. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (3). doi:10.1002/14651858.CD003336.pub3
The membrane expression of P-selectin, but not monocyte-platelet aggregates, is influenced by variability in response to aspirin in patients with coronary artery disease
Kuzniatsova, N., Shantsila, E., Lip, G. Y. H., & Blann, A. D. (2014). The membrane expression of P-selectin, but not monocyte-platelet aggregates, is influenced by variability in response to aspirin in patients with coronary artery disease. PLATELETS, 25(2), 142-143. doi:10.3109/09537104.2012.739720
Circulating microparticles: challenges and perspectives of flow cytometric assessment
Shantsila, E., Montoro-Garcia, S., Gallego, P., & Lip, G. Y. H. (2014). Circulating microparticles: challenges and perspectives of flow cytometric assessment. THROMBOSIS AND HAEMOSTASIS, 111(6), 1009-1014. doi:10.1160/TH13-11-0937
Use of novel oral anticoagulants in patients with heart failure.
Shantsila, E., & Lip, G. Y. H. (2014). Use of novel oral anticoagulants in patients with heart failure.. Current treatment options in cardiovascular medicine, 16(2), 285. doi:10.1007/s11936-013-0285-y
The Role of Monocytes in Angiogenesis and Atherosclerosis
Jaipersad, A. S., Lip, G. Y. H., Silverman, S., & Shantsila, E. (2014). The Role of Monocytes in Angiogenesis and Atherosclerosis. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 63(1), 1-11. doi:10.1016/j.jacc.2013.09.019
Antithrombotic treatment of atrial fibrillation in general practice: application of the GRASP-AF audit tool
Shantsila, E., Wolff, A., Lip, G. Y. H., & Lane, D. A. (2014). Antithrombotic treatment of atrial fibrillation in general practice: application of the GRASP-AF audit tool. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1104). Retrieved from https://www.webofscience.com/
Monocyte subpopulation counts and function are associated with global longitudinal strain in patients with normal ejection fraction after ST elevation mycardial infarction
Ghattas, A., Shantsila, E., Griffiths, H., & Lip, G. (2014). Monocyte subpopulation counts and function are associated with global longitudinal strain in patients with normal ejection fraction after ST elevation mycardial infarction. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 488). Retrieved from https://www.webofscience.com/
Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis
Shantsila, E., Tapp, L. D., Wrigley, B. J., Pamukcu, B., Apostolakis, S., Montoro-Garcia, S., & Lip, G. Y. H. (2014). Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis. ATHEROSCLEROSIS, 234(1), 4-10. doi:10.1016/j.atherosclerosis.2014.02.009
Monocytes circulate in constant reversible interaction with platelets in a [Ca2+]-dependent manner
Shantsila, E., Montoro-Garcia, S., & Lip, G. Y. H. (2014). Monocytes circulate in constant reversible interaction with platelets in a [Ca2+]-dependent manner. PLATELETS, 25(3), 197-201. doi:10.3109/09537104.2013.784248
One year re-infarction rates in non-culprit vessels following index ST elevation myocardial infarction in patients with multivessel coronary artery disease
Brown, R. A., Shantsila, E., Khan, J., Lee, H. L., Connolly, D. L., Ahmad, R., . . . Varma, C. (2014). One year re-infarction rates in non-culprit vessels following index ST elevation myocardial infarction in patients with multivessel coronary artery disease. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 479-480). Retrieved from https://www.webofscience.com/
Potential value of targeting von Willebrand factor in atherosclerotic cardiovascular disease
Montoro-Garcia, S., Shantsila, E., & Lip, G. Y. H. (2014). Potential value of targeting von Willebrand factor in atherosclerotic cardiovascular disease. EXPERT OPINION ON THERAPEUTIC TARGETS, 18(1), 43-53. doi:10.1517/14728222.2013.840585
Simultaneous computerised activation of the primary percutaneous coronary intervention pathway reduced out-of-hours door-to-balloon time but did not improve mortality
Brown, R. A., Lip, G. Y. H., Shantsila, E., Connolly, D. L., Davis, R., Badri, M., . . . Varma, C. (2014). Simultaneous computerised activation of the primary percutaneous coronary intervention pathway reduced out-of-hours door-to-balloon time but did not improve mortality. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1173). Retrieved from https://www.webofscience.com/
Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin
Montoro-Garcia, S., Shantsila, E., Hernandez-Romero, D., Jover, E., Valdes, M., Marin, F., & Lip, G. Y. H. (2014). Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin. BRITISH JOURNAL OF HAEMATOLOGY, 166(4), 571-580. doi:10.1111/bjh.12913
Ventricular-arterial coupling in obstructive sleep apnea
Shantsila, A., Shantsila, E., Butt, M., Khair, O. A., Dwivedi, G., & Lip, G. Y. H. (2014). Ventricular-arterial coupling in obstructive sleep apnea. JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 8(9), 624-629. doi:10.1016/j.jash.2014.05.013
2013
The effect of statin therapy withdrawal on monocyte subsets
Jaipersad, A. S., Shantsila, E., Blann, A., & Lip, G. Y. H. (2013). The effect of statin therapy withdrawal on monocyte subsets. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 43(12), 1307-1313. doi:10.1111/eci.12183
The immunological axis in heart failure: importance of the leukocyte differential
Vaduganathan, M., Greene, S. J., Butler, J., Sabbah, H. N., Shantsila, E., Lip, G. Y. H., & Gheorghiade, M. (2013). The immunological axis in heart failure: importance of the leukocyte differential. HEART FAILURE REVIEWS, 18(6), 835-845. doi:10.1007/s10741-012-9352-9
Monocytes in Coronary Artery Disease and Atherosclerosis Where Are We Now?
Ghattas, A., Griffiths, H. R., Devitt, A., Lip, G. Y. H., & Shantsila, E. (2013). Monocytes in Coronary Artery Disease and Atherosclerosis Where Are We Now?. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 62(17), 1541-1551. doi:10.1016/j.jacc.2013.07.043
Pharmacokinetic considerations for antithrombotic therapies in stroke
Apostolakis, S., Lip, G. Y. H., & Shantsila, E. (2013). Pharmacokinetic considerations for antithrombotic therapies in stroke. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 9(10), 1335-1347. doi:10.1517/17425255.2013.808331
Stroke Prevention in Atrial Fibrillation in Heart Failure
Shantsila, E., & Lip, G. Y. H. (2013). Stroke Prevention in Atrial Fibrillation in Heart Failure. HEART FAILURE CLINICS, 9(4), 427-+. doi:10.1016/j.hfc.2013.07.008
Ultrasound-assisted thrombolysis with streptokinase improves thrombus resolution with minimal distal embolisation
Adzerikho, I., Shantsila, E., Minchenya, V., & Kulak, A. (2013). Ultrasound-assisted thrombolysis with streptokinase improves thrombus resolution with minimal distal embolisation. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 36(3), 263-270. doi:10.1007/s11239-012-0850-3
Receptors to interleukin-6 and adhesion molecules on circulating monocyte subsets in acute myocardial infarction
Shantsila, E., Tapp, L. D., Wrigley, B. J., Montoro-Garcia, S., & Lip, G. Y. H. (2013). Receptors to interleukin-6 and adhesion molecules on circulating monocyte subsets in acute myocardial infarction. THROMBOSIS AND HAEMOSTASIS, 110(2), 340-348. doi:10.1160/TH13-02-0085
Evaluation of Carotid Plaque Neovascularization Using Contrast Ultrasound
Jaipersad, A. S., Shantsila, A., Silverman, S., Lip, G. Y. H., & Shantsila, E. (2013). Evaluation of Carotid Plaque Neovascularization Using Contrast Ultrasound. ANGIOLOGY, 64(6), 447-450. doi:10.1177/0003319712457013
A comprehensive assessment of cardiac structure and function in patients with treated malignant phase hypertension: The West Birmingham Malignant Hypertension project
Shantsila, A., Dwivedi, G., Shantsila, E., Butt, M., Beevers, D. G., & Lip, G. Y. H. (2013). A comprehensive assessment of cardiac structure and function in patients with treated malignant phase hypertension: The West Birmingham Malignant Hypertension project. INTERNATIONAL JOURNAL OF CARDIOLOGY, 167(1), 67-72. doi:10.1016/j.ijcard.2011.11.077
Increased expression of cell adhesion molecule receptors on monocyte subsets in ischaemic heart failure
Wrigley, B. J., Shantsila, E., Tapp, L. D., & Lip, G. Y. H. (2013). Increased expression of cell adhesion molecule receptors on monocyte subsets in ischaemic heart failure. THROMBOSIS AND HAEMOSTASIS, 110(1), 92-100. doi:10.1160/TH13-02-0088
Left Ventricular Fibrosis in Atrial Fibrillation
Shantsila, E., Shantsila, A., Blann, A. D., & Lip, G. Y. H. (2013). Left Ventricular Fibrosis in Atrial Fibrillation. AMERICAN JOURNAL OF CARDIOLOGY, 111(7), 996-1001. doi:10.1016/j.amjcard.2012.12.005
Small-size circulating microparticles in acute coronary syndromes: Relevance to fibrinolytic status, reparative markers and outcomes
Montoro-Garcia, S., Shantsila, E., Tapp, L. D., Lopez-Cuenca, A., Isabel Romero, A., Hernandez-Romero, D., . . . Lip, G. Y. H. (2013). Small-size circulating microparticles in acute coronary syndromes: Relevance to fibrinolytic status, reparative markers and outcomes. ATHEROSCLEROSIS, 227(2), 313-322. doi:10.1016/j.atherosclerosis.2013.01.028
CXCR4 positive and angiogenic monocytes in myocardial infarction
Shantsila, E., Tapp, L. D., Wrigley, B. J., Montoro-Garcia, S., & Lip, G. Y. H. (2013). CXCR4 positive and angiogenic monocytes in myocardial infarction. THROMBOSIS AND HAEMOSTASIS, 109(2), 255-262. doi:10.1160/TH12-06-0395
TLR4 expression on monocyte subsets in myocardial infarction
Tapp, L. D., Shantsila, E., Wrigley, B. J., Montoro-Garcia, S., & Lip, G. Y. H. (2013). TLR4 expression on monocyte subsets in myocardial infarction. JOURNAL OF INTERNAL MEDICINE, 273(3), 294-305. doi:10.1111/joim.12011
CD14++CD16+ monocytes in patients with acute ischaemic heart failure
Wrigley, B. J., Shantsila, E., Tapp, L. D., & Lip, G. Y. H. (2013). CD14++CD16+ monocytes in patients with acute ischaemic heart failure. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 43(2), 121-130. doi:10.1111/eci.12023
Common Clinical Indications for Anticoagulation
Krishnamoorthy, S., Khoo, C. W., Shantsila, E., & Lip, G. Y. H. (2013). Common Clinical Indications for Anticoagulation. In Handbook of Oral Anticoagulation (pp. 7-31). Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8_2
Future Directions
Shantsila, E., & Lip, G. Y. H. (2013). Future Directions. In Handbook of Oral Anticoagulation (pp. 87-88). Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8_6
Handbook of Oral Anticoagulation
Lip, G. Y. H., & Shantsila, E. (Eds.) (2013). Handbook of Oral Anticoagulation. Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8
Increased Formation of Monocyte-Platelet Aggregates in Ischemic Heart Failure
Wrigley, B. J., Shantsila, E., Tapp, L. D., & Lip, G. Y. H. (2013). Increased Formation of Monocyte-Platelet Aggregates in Ischemic Heart Failure. CIRCULATION-HEART FAILURE, 6(1), 127-+. doi:10.1161/CIRCHEARTFAILURE.112.968073
New Oral Anticoagulants
Shantsila, E., Apostolakis, S., & Lip, G. Y. H. (2013). New Oral Anticoagulants. In Handbook of Oral Anticoagulation (pp. 53-86). Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8_5
Recent advances in management of atrial fibrillation in patients with heart failure
Shantsila, E., & Lip, G. Y. H. (2013). Recent advances in management of atrial fibrillation in patients with heart failure. CURRENT OPINION IN CARDIOLOGY, 28(2), 197-208. doi:10.1097/HCO.0b013e32835bd465
The Coagulation Pathway and Approaches to Anticoagulation
Tay, K. H., Shantsila, E., & Lip, G. Y. H. (2013). The Coagulation Pathway and Approaches to Anticoagulation. In Handbook of Oral Anticoagulation (pp. 1-5). Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8_1
Vitamin K Antagonists and Their Limitations
Khoo, C. W., Shantsila, E., & Lip, G. Y. H. (2013). Vitamin K Antagonists and Their Limitations. In Handbook of Oral Anticoagulation (pp. 33-40). Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8_3
2012
A contemporary viewpoint on 'aspirin resistance'
Kuzniatsova, N., Shantsila, E., Blann, A., & Lip, G. Y. H. (2012). A contemporary viewpoint on 'aspirin resistance'. ANNALS OF MEDICINE, 44(8), 773-783. doi:10.3109/07853890.2011.605388
A contemporary view on endothelial function in heart failure
Shantsila, E., Wrigley, B. J., Blann, A. D., Gill, P. S., & Lip, G. Y. H. (2012). A contemporary view on endothelial function in heart failure. EUROPEAN JOURNAL OF HEART FAILURE, 14(8), 873-881. doi:10.1093/eurjhf/hfs066
An innovative flow cytometric approach for small-size platelet microparticles: Influence of calcium
Montoro-Garcia, S., Shantsila, E., Orenes-Pinero, E., Luisa Lozano, M., & Lip, G. Y. H. (2012). An innovative flow cytometric approach for small-size platelet microparticles: Influence of calcium. THROMBOSIS AND HAEMOSTASIS, 108(2), 373-383. doi:10.1160/TH12-02-0120
The effects of exercise and diurnal variation on monocyte subsets and monocyte-platelet aggregates
Shantsila, E., Tapp, L. D., Wrigley, B. J., Montoro-Garcia, S., Ghattas, A., Jaipersad, A., & Lip, G. Y. H. (2012). The effects of exercise and diurnal variation on monocyte subsets and monocyte-platelet aggregates. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 42(8), 832-839. doi:10.1111/j.1365-2362.2012.02656.x
Fibrinolytic status hi acute coronary syndromes: Evidence of differences in relation to clinical features and pathophysiological pathways
Shantsila, E., Montoro-Garcia, S., Tapp, L. D., Apostolakis, S., Wrigley, B. J., & Lip, G. Y. H. (2012). Fibrinolytic status hi acute coronary syndromes: Evidence of differences in relation to clinical features and pathophysiological pathways. THROMBOSIS AND HAEMOSTASIS, 108(1), 32-40. doi:10.1160/TH12-01-0011
Monocyte-derived and CD34+/KDR+ endothelial progenitor cells in heart failure
Shantsila, E., Wrigley, B. J., Shantsila, A., Tapp, L. D., Gill, P. S., & Lip, G. Y. H. (2012). Monocyte-derived and CD34+/KDR+ endothelial progenitor cells in heart failure. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 10(7), 1252-1261. doi:10.1111/j.1538-7836.2012.04753.x
The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction
Tapp, L. D., Shantsila, E., Wrigley, B. J., Pamukcu, B., & Lip, G. Y. H. (2012). The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 10(7), 1231-1241. doi:10.1111/j.1538-7836.2011.04603.x
Vascular ventricular coupling in patients with malignant phase hypertension: the West Birmingham malignant hypertension project
Shantsila, A., Dwivedi, G., Shantsila, E., Steeds, R. P., Beevers, G., & Lip, G. Y. H. (2012). Vascular ventricular coupling in patients with malignant phase hypertension: the West Birmingham malignant hypertension project. HYPERTENSION RESEARCH, 35(7), 725-728. doi:10.1038/hr.2012.18
Blood leukocytes in heart failure with preserved ejection fraction: Impact on prognosis
Shantsila, E., Bialiuk, N., Navitski, D., Pyrochkin, A., Gill, P. S., Pyrochkin, V., . . . Lip, G. Y. H. (2012). Blood leukocytes in heart failure with preserved ejection fraction: Impact on prognosis. INTERNATIONAL JOURNAL OF CARDIOLOGY, 155(2), 337-338. doi:10.1016/j.ijcard.2011.12.048
Pharmacological Modulation of Microparticle Release: New Strategies for the Management of Atherothrombotic Vascular Disorders
Montoro-Garcia, S., Orenes-Pinero, E., Marin, F., Mariano, V., Lip, G. Y. H., & Shantsila, E. (2012). Pharmacological Modulation of Microparticle Release: New Strategies for the Management of Atherothrombotic Vascular Disorders. CURRENT PHARMACEUTICAL DESIGN, 18(6), 840-849. doi:10.2174/138161212799277789
2011
Systolic heart failure in South Asians
Shantsila, E., Lip, G. Y. H., & Gill, P. S. (2011). Systolic heart failure in South Asians. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 65(12), 1274-1282. doi:10.1111/j.1742-1241.2011.02796.x
The Quest for New Anticoagulants: From Clinical Development to Clinical Practice
Apostolakis, S., Lip, G. Y. H., Lane, D. A., & Shantsila, E. (2011). The Quest for New Anticoagulants: From Clinical Development to Clinical Practice. CARDIOVASCULAR THERAPEUTICS, 29(6), E12-E22. doi:10.1111/j.1755-5922.2010.00160.x
Circulating microparticles: new insights into the biochemical basis of microparticle release and activity
Montoro-Garcia, S., Shantsila, E., Marin, F., Blann, A., & Lip, G. Y. H. (2011). Circulating microparticles: new insights into the biochemical basis of microparticle release and activity. BASIC RESEARCH IN CARDIOLOGY, 106(6), 911-923. doi:10.1007/s00395-011-0198-4
Endothelial dysfunction and diurnal variation of blood pressure: night secrets of arterial hypertension?
Shantsila, A., & Shantsila, E. (2011). Endothelial dysfunction and diurnal variation of blood pressure: night secrets of arterial hypertension?. JOURNAL OF HUMAN HYPERTENSION, 25(11), 653-655. doi:10.1038/jhh.2011.54
Ethnic Differences in Macrovascular and Microvascular Function in Systolic Heart Failure
Shantsila, E., Wrigley, B., Shantsila, A., Tapp, L. D., Blann, A. D., Gill, P. S., & Lip, G. Y. H. (2011). Ethnic Differences in Macrovascular and Microvascular Function in Systolic Heart Failure. CIRCULATION-HEART FAILURE, 4(6), 754-762. doi:10.1161/CIRCHEARTFAILURE.111.962365
The role of monocytes and inflammation in the pathophysiology of heart failure
Wrigley, B. J., Lip, G. Y. H., & Shantsila, E. (2011). The role of monocytes and inflammation in the pathophysiology of heart failure. EUROPEAN JOURNAL OF HEART FAILURE, 13(11), 1161-1171. doi:10.1093/eurjhf/hfr122
Myocardial Perfusion by Myocardial Contrast Echocardiography and Endothelial Dysfunction in Obstructive Sleep Apnea
Butt, M., Khair, O. A., Dwivedi, G., Shantsila, A., Shantsila, E., & Lip, G. Y. H. (2011). Myocardial Perfusion by Myocardial Contrast Echocardiography and Endothelial Dysfunction in Obstructive Sleep Apnea. HYPERTENSION, 58(3), 417-U177. doi:10.1161/HYPERTENSIONAHA.111.170910
Atorvastatin and its collateral effects on microparticles
Montoro-Garcia, S., Lip, G. Y. H., & Shantsila, E. (2011). Atorvastatin and its collateral effects on microparticles. THROMBOSIS AND HAEMOSTASIS, 106(2), 185-186. doi:10.1160/TH11-05-0335
The CD40-CD40L system in cardiovascular disease
Pamukcu, B., Lip, G. Y. H., Snezhitskiy, V., & Shantsila, E. (2011). The CD40-CD40L system in cardiovascular disease. ANNALS OF MEDICINE, 43(5), 331-340. doi:10.3109/07853890.2010.546362
The nuclear factor - kappa B pathway in atherosclerosis: A potential therapeutic target for atherothrombotic vascular disease
Pamukcu, B., Lip, G. Y. H., & Shantsila, E. (2011). The nuclear factor - kappa B pathway in atherosclerosis: A potential therapeutic target for atherothrombotic vascular disease. THROMBOSIS RESEARCH, 128(2), 117-123. doi:10.1016/j.thromres.2011.03.025
Endothelial Progenitor Cells and Circulating Endothelial Cells in Early Prostate Cancer: A Comparison With Plasma Vascular Markers
Blann, A. D., Balakrishnan, B., Shantsila, E., Ryan, P., & Lip, G. Y. H. (2011). Endothelial Progenitor Cells and Circulating Endothelial Cells in Early Prostate Cancer: A Comparison With Plasma Vascular Markers. PROSTATE, 71(10), 1047-1053. doi:10.1002/pros.21319
Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology
Shantsila, E., Wrigley, B., Tapp, L., Apostolakis, S., Montoro-Garcia, S., Drayson, M. T., & Lip, G. Y. H. (2011). Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 9(5), 1056-1066. doi:10.1111/j.1538-7836.2011.04244.x
Monocytes: Possible mediators of benefits and harms from physical activity?
Shantsila, E., & Lip, G. Y. H. (2011). Monocytes: Possible mediators of benefits and harms from physical activity?. THROMBOSIS AND HAEMOSTASIS, 105(3), 387-389. doi:10.1160/TH11-01-0009
Persistent Macrovascular and Microvascular Dysfunction in Patients With Malignant Hypertension
Shantsila, A., Dwivedi, G., Shantsila, E., Butt, M., Beevers, D. G., & Lip, G. Y. H. (2011). Persistent Macrovascular and Microvascular Dysfunction in Patients With Malignant Hypertension. HYPERTENSION, 57(3), 490-496. doi:10.1161/HYPERTENSIONAHA.110.166314
The Risk of Thromboembolism in Heart Failure: Does It Merit Anticoagulation Therapy?
Shantsila, E., & Lip, G. Y. H. (2011). The Risk of Thromboembolism in Heart Failure: Does It Merit Anticoagulation Therapy?. AMERICAN JOURNAL OF CARDIOLOGY, 107(4), 558-560. doi:10.1016/j.amjcard.2010.10.029
Platelet reactivity in prolonged stress disorders-A link with cardiovascular disease?
Montoro-Garcia, S., Shantsila, E., & Lip, G. Y. H. (2011). Platelet reactivity in prolonged stress disorders-A link with cardiovascular disease?. PSYCHONEUROENDOCRINOLOGY, 36(2), 159-160. doi:10.1016/j.psyneuen.2010.08.010
Antithrombotic therapy after percutaneous coronary intervention in anticoagulated patients: a fine balance between thrombosis and bleeding.
Ghattas, A., Shantsila, E., & Lip, G. Y. H. (2011). Antithrombotic therapy after percutaneous coronary intervention in anticoagulated patients: a fine balance between thrombosis and bleeding.. Therapeutic advances in cardiovascular disease, 5(1), 5-9. doi:10.1177/1753944710397225
2010
Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis
Shantsila, E., Kamphuisen, P. W., & Lip, G. Y. H. (2010). Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 8(11), 2358-2368. doi:10.1111/j.1538-7836.2010.04007.x
Malignant Hypertension: A Rare Problem or is it Underdiagnosed?
Shantsila, A., Shantsila, E., & Lip, G. Y. H. (2010). Malignant Hypertension: A Rare Problem or is it Underdiagnosed?. CURRENT VASCULAR PHARMACOLOGY, 8(6), 775-779. doi:10.2174/157016110793563834
Soluble Fms-Like Tyrosine Kinase-1-A Novel Marker for Atherosclerotic Progression? -
Pamukcu, B., Shantsila, E., & Lip, G. Y. H. (2010). Soluble Fms-Like Tyrosine Kinase-1-A Novel Marker for Atherosclerotic Progression? -. CIRCULATION JOURNAL, 74(10), 2064-2065. doi:10.1253/circj.CJ-10-0621
Percutaneous Coronary Intervention in Anticoagulated Patients and Balancing the Risk of Stroke and Bleeding To Interrupt or Not To Interrupt?
Wrigley, B. J., Shantsila, E., & Lip, G. Y. H. (2010). Percutaneous Coronary Intervention in Anticoagulated Patients and Balancing the Risk of Stroke and Bleeding To Interrupt or Not To Interrupt?. CHEST, 138(4), 771-774. doi:10.1378/chest.10-0789
The role of monocytes in atherosclerotic coronary artery disease
Pamukcu, B., Lip, G. Y. H., Devitt, A., Griffiths, H., & Shantsila, E. (2010). The role of monocytes in atherosclerotic coronary artery disease. ANNALS OF MEDICINE, 42(6), 394-403. doi:10.3109/07853890.2010.497767
Circulating monocytes and atherogenesis: From animal experiments to human studies
Shantsila, E., Devitt, A., & Lip, G. Y. H. (2010). Circulating monocytes and atherogenesis: From animal experiments to human studies. THROMBOSIS AND HAEMOSTASIS, 104(2), 191-193. doi:10.1160/TH10-03-0176
Circulating progenitor cells in patients with atrial fibrillation and their relation with serum markers of inflammation and angiogenesis
Watson, T., Shantsila, E., Blann, A., & Lip, G. Y. H. (2010). Circulating progenitor cells in patients with atrial fibrillation and their relation with serum markers of inflammation and angiogenesis. THROMBOSIS AND HAEMOSTASIS, 104(2), 327-334. doi:10.1160/TH10-01-0024
Antithrombotic therapy in anticoagulated patients with atrial fibrillation presenting with acute coronary syndromes and/or undergoing percutaneous coronary intervention/stenting
Wrigley, B. J., Tapp, L. D., Shantsila, E., & Lip, G. Y. H. (2010). Antithrombotic therapy in anticoagulated patients with atrial fibrillation presenting with acute coronary syndromes and/or undergoing percutaneous coronary intervention/stenting. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 120(7-8), 290-293. doi:10.20452/pamw.949
Novel oral anticoagulants: the potential relegation of vitamin K antagonists in clinical practice
Wrigley, B. J., Lip, G. Y. H., & Shantsila, E. (2010). Novel oral anticoagulants: the potential relegation of vitamin K antagonists in clinical practice. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 64(7), 835-838. doi:10.1111/j.1742-1241.2010.02351.x
Arterial stiffening in hypertension: beyond blood pressure levels
Shantsila, A., & Shantsila, E. (2010). Arterial stiffening in hypertension: beyond blood pressure levels. JOURNAL OF HUMAN HYPERTENSION, 24(5), 303-305. doi:10.1038/jhh.2009.101
Role of Ticagrelor in Clopidogrel Nonresponders: Resistance Is Futile?
Tapp, L., Shantsila, E., & Lip, G. Y. H. (2010). Role of Ticagrelor in Clopidogrel Nonresponders: Resistance Is Futile?. CIRCULATION, 121(10), 1169-1171. doi:10.1161/CIR.0b013e3181d8d929
Coronary Atherosclerosis in Rheumatoid Arthritis: Could Endothelial Progenitor Cells Be the Missing Link?
Wrigley, B. J., Lip, G. Y. H., & Shantsila, E. (2010). Coronary Atherosclerosis in Rheumatoid Arthritis: Could Endothelial Progenitor Cells Be the Missing Link?. JOURNAL OF RHEUMATOLOGY, 37(3), 479-481. doi:10.3899/jrheum.091341
Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair?
Apostolakis, S., Lip, G. Y. H., & Shantsila, E. (2010). Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair?. CARDIOVASCULAR RESEARCH, 85(4), 649-660. doi:10.1093/cvr/cvp327
Endothelial progenitor cells: what use for the cardiologist?
Siddique, A., Shantsila, E., Lip, G. Y., & Varma, C. (2010). Endothelial progenitor cells: what use for the cardiologist?. Journal of angiogenesis research, 2, 6. doi:10.1186/2040-2384-2-6
Aspirin-A Drug Whose Time Has Gone?
Tapp, L., Shantsila, E., & Lip, G. Y. H. (2010). Aspirin-A Drug Whose Time Has Gone?. AMERICAN JOURNAL OF CARDIOLOGY, 105(4), 577-578. doi:10.1016/j.amjcard.2009.10.026
The effects of exercise stress testing, diurnal variation and temporal decline on circulating progenitor cells
Watson, T., Shantsila, E., Karthikeyan, V. J., Jessani, S., Goon, P. K., & Lip, G. Y. H. (2010). The effects of exercise stress testing, diurnal variation and temporal decline on circulating progenitor cells. THROMBOSIS AND HAEMOSTASIS, 103(2), 419-425. doi:10.1160/TH09-06-0386
Peripheral Blood Monocyte Subset Assessment in Non-ST-Segment Elevation Myocardial Infarction Is Required Reply
Shantsila, E., & Lip, G. Y. H. (2010). Peripheral Blood Monocyte Subset Assessment in Non-ST-Segment Elevation Myocardial Infarction Is Required Reply. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 55(2), 170-171. doi:10.1016/j.jacc.2009.08.044
ATRIAL FIBRILLATION Blockade of the renin-angiotensin system in atrial fibrillation
Kuzniatsova, N., Shantsila, E., & Lip, G. Y. H. (2010). ATRIAL FIBRILLATION Blockade of the renin-angiotensin system in atrial fibrillation. NATURE REVIEWS CARDIOLOGY, 7(8), 428-430. doi:10.1038/nrcardio.2010.103
2009
Antithrombotic therapy for heart failure in sinus rhythm
Subramaniam, V., Davis, R. C., Shantsila, E., & Lip, G. Y. H. (2009). Antithrombotic therapy for heart failure in sinus rhythm. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 23(6), 705-717. doi:10.1111/j.1472-8206.2009.00776.x
Evidence guided antiplatelet treatment: Time to move from bench to bedside
Apostolakis, S., Shantsila, E., & Lip, G. Y. H. (2009). Evidence guided antiplatelet treatment: Time to move from bench to bedside. THROMBOSIS RESEARCH, 124(6), 649-650. doi:10.1016/j.thromres.2009.04.020
Heparin-Induced Thrombocytopenia <i>Response</i>
Shantsila, E., & Lip, G. Y. H. (2009). Heparin-Induced Thrombocytopenia <i>Response</i>. CHEST, 136(6), 1704-1705. doi:10.1378/chest.09-1753
Impaired glucose tolerance and endothelial damage, as assessed by levels of von Willebrand factor and circulating endothelial cells, following acute myocardial infarction
Jessani, S. S., Lane, D. A., Shantsila, E., Watson, T., Millane, T. A., & Lip, G. Y. H. (2009). Impaired glucose tolerance and endothelial damage, as assessed by levels of von Willebrand factor and circulating endothelial cells, following acute myocardial infarction. ANNALS OF MEDICINE, 41(8), 608-618. doi:10.1080/07853890903159256
Microparticles and Arterial Disease
Blann, A., Shantsilla, E., & Shantsila, A. (2009). Microparticles and Arterial Disease. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 35(5), 488-496. doi:10.1055/s-0029-1234144
Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation"
Apostolakis, S., Shantsila, E., Lip, G. Y. H., & Lane, D. A. (2009). Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation". THROMBOSIS AND HAEMOSTASIS, 102(5), 914-915. doi:10.1160/TH09-08-0563
Systemic inflammation as a driver of vascular calcification: a proof of concept
Shantsila, E., & Lip, G. Y. H. (2009). Systemic inflammation as a driver of vascular calcification: a proof of concept. JOURNAL OF INTERNAL MEDICINE, 266(5), 453-456. doi:10.1111/j.1365-2796.2009.02138.x
The role of monocytes in thrombotic disorders Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms
Shantsila, E., & Lip, G. Y. H. (2009). The role of monocytes in thrombotic disorders Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms. THROMBOSIS AND HAEMOSTASIS, 102(5), 916-924. doi:10.1160/TH09-01-0023
New Anticoagulants for the Prevention of Deep Venous Thrombosis Time to Consider Cost Effectiveness?
Apostolakis, S., Shantsila, E., & Lip, G. Y. H. (2009). New Anticoagulants for the Prevention of Deep Venous Thrombosis Time to Consider Cost Effectiveness?. PHARMACOECONOMICS, 27(10), 793-795. doi:10.2165/11313780-000000000-00000
Monocytes in Acute Coronary Syndromes
Shantsila, E., & Lip, G. Y. H. (2009). Monocytes in Acute Coronary Syndromes. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 29(10), 1433-1U66. doi:10.1161/ATVBAHA.108.180513
Vascular Imaging as a Cardiovascular Risk Stratification Tool in Systemic Lupus Erythematosus
Apostolakis, S., Shantsila, E., & Lip, G. Y. H. (2009). Vascular Imaging as a Cardiovascular Risk Stratification Tool in Systemic Lupus Erythematosus. JOURNAL OF RHEUMATOLOGY, 36(10), 2141-2143. doi:10.3899/jrheum.090640
Angiopoietins and Preeclampsia: New Perspectives in the Quest for Markers
Apostolakis, S., Shantsila, E., & Lip, G. Y. H. (2009). Angiopoietins and Preeclampsia: New Perspectives in the Quest for Markers. AMERICAN JOURNAL OF HYPERTENSION, 22(8), 820. doi:10.1038/ajh.2009.108
The endothelium and thrombotic risk in heart failure
Shantsila, E., & Lip, G. Y. H. (2009). The endothelium and thrombotic risk in heart failure. THROMBOSIS AND HAEMOSTASIS, 102(2), 185-187. doi:10.1160/TH09-06-0344
Monocyte Diversity in Myocardial Infarction
Shantsila, E., & Lip, G. Y. H. (2009). Monocyte Diversity in Myocardial Infarction. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 54(2), 139-142. doi:10.1016/j.jacc.2009.03.047
Fondaparinux: an overview.
Nadar, S. K., Goyal, D., Shantsila, E., Banerjee, P., & Lip, G. Y. H. (2009). Fondaparinux: an overview.. Expert review of cardiovascular therapy, 7(6), 577-585. doi:10.1586/erc.09.19
Heparin-Induced Thrombocytopenia A Contemporary Clinical Approach to Diagnosis and Management
Shantsila, E., Lip, G. Y. H., & Chong, B. H. (2009). Heparin-Induced Thrombocytopenia A Contemporary Clinical Approach to Diagnosis and Management. CHEST, 135(6), 1651-1664. doi:10.1378/chest.08-2830
New antiplatelet drugs: beyond aspirin and clopidogrel
Siddique, A., Butt, M., Shantsila, E., & Lip, G. Y. H. (2009). New antiplatelet drugs: beyond aspirin and clopidogrel. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 63(5), 776-789. doi:10.1111/j.1742-1241.2009.02058.x
AZD6140 and bleeding: towards safer antiplatelet therapy?
Siddique, A., Shantsila, E., & Lip, G. Y. H. (2009). AZD6140 and bleeding: towards safer antiplatelet therapy?. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 63(4), 537-539. doi:10.1111/j.1742-1241.2008.01963.x
Novel oral anticoagulants
Khoo, C. W., Tay, K. -H., Shantsila, E., & Lip, G. Y. H. (2009). Novel oral anticoagulants. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 63(4), 630-641. doi:10.1111/j.1742-1241.2009.02011.x
Mechanisms of thrombogenesis in atrial fibrillation Reply
Lip, G. Y. H., & Shantsila, E. (2009). Mechanisms of thrombogenesis in atrial fibrillation Reply. LANCET, 373(9668), 1006-1007. doi:10.1016/S0140-6736(09)60605-X
Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage/dysfunction
Foster, W., Shantsila, E., Carruthers, D., Lip, G. Y. H., & Blann, A. D. (2009). Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage/dysfunction. RHEUMATOLOGY, 48(3), 285-288. doi:10.1093/rheumatology/ken486
Rivaroxaban, a new oral factor Xa inhibitor, provides new data on anticoagulation
Siddique, A., Lip, G. Y. H., & Shantsila, E. (2009). Rivaroxaban, a new oral factor Xa inhibitor, provides new data on anticoagulation. Therapy, 6(2), 187-189. doi:10.2217/14750708.6.2.187
Variability of response to antiplatelet therapy: what should we do next?
Shantsila, E., & Lip, G. Y. H. (2009). Variability of response to antiplatelet therapy: what should we do next?. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 23(1), 19-22. doi:10.1111/j.1472-8206.2008.00674.x
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
Watson, T., Shantsila, E., & Lip, G. Y. H. (2009). Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. LANCET, 373(9658), 155-166. doi:10.1016/S0140-6736(09)60040-4
Angiopoietins in arterial hypertension: a mechanism of adaptation or a target for treatment?
Shantsila, E., & Lip, G. Y. H. (2009). Angiopoietins in arterial hypertension: a mechanism of adaptation or a target for treatment?. JOURNAL OF HYPERTENSION, 27(8), 1524-1526. doi:10.1097/HJH.0b013e32832dd5c4
Endothelial function and endothelial progenitors: possible mediators of the benefits from physical exercise?
Shantsila, E., & Lip, G. Y. H. (2009). Endothelial function and endothelial progenitors: possible mediators of the benefits from physical exercise?. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 16(4), 401-403. doi:10.1097/HJR.0b013e32832d3c76
Endothelial microparticles: a universal marker of vascular health?
Shantsila, E. (2009). Endothelial microparticles: a universal marker of vascular health?. JOURNAL OF HUMAN HYPERTENSION, 23(5), 359-361. doi:10.1038/jhh.2008.138
Pro: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation"
Healey, J. S. (2009). Pro: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation". THROMBOSIS AND HAEMOSTASIS, 102(5), 912-913. doi:10.1160/TH09-06-0369
Targeting the arterial wall, but what is the target?
Shantsila, E., & Lim, H. S. (2009). Targeting the arterial wall, but what is the target?. JOURNAL OF HUMAN HYPERTENSION, 23(1), 1-3. doi:10.1038/jhh.2008.55
2008
Predicting thrombotic events: Creating a complex approach for a complex condition
Shantsila, E., & Lip, G. Y. H. (2008). Predicting thrombotic events: Creating a complex approach for a complex condition. THROMBOSIS AND HAEMOSTASIS, 100(6), 962-964. doi:10.1160/TH08-10-0681
The search for new anticoagulants: dabigatran etexilate
Siddique, A., Shantsila, E., & Lip, G. Y. H. (2008). The search for new anticoagulants: dabigatran etexilate. Therapy, 5(6), 793-796. doi:10.2217/14750708.5.6.793
Apixaban, an oral, direct inhibitor of activated Factor Xa
Shantsila, E., & Lip, G. Y. H. (2008). Apixaban, an oral, direct inhibitor of activated Factor Xa. CURRENT OPINION IN INVESTIGATIONAL DRUGS, 9(9), 1020-1033. Retrieved from https://www.webofscience.com/
'Aspirin resistance' or treatment non-compliance: Which is to blame for cardiovascular complications?
Shantsila, E., & Lip, G. Y. H. (2008). 'Aspirin resistance' or treatment non-compliance: Which is to blame for cardiovascular complications?. JOURNAL OF TRANSLATIONAL MEDICINE, 6. doi:10.1186/1479-5876-6-47
Beyond glucose levels in diabetic patients with coronary artery disease: Platelet activity and non-responsiveness to antiplatelet therapy
Shantsila, E., & Lip, G. Y. H. (2008). Beyond glucose levels in diabetic patients with coronary artery disease: Platelet activity and non-responsiveness to antiplatelet therapy. THROMBOSIS AND HAEMOSTASIS, 100(1), 7-8. doi:10.1160/TH08-06-0342
Circulating endothelial cells in health and disease: how do we best quantify them?
Shantsila, E., & Lip, G. Y. H. (2008). Circulating endothelial cells in health and disease: how do we best quantify them?. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 6(6), 1021-1024. doi:10.1111/j.1538-7836.2008.02985.x
Statins and inflammation: Reciprocal effectors to endothelial progenitors?
Shantsila, E., Watson, T., & Lip, G. Y. H. (2008). Statins and inflammation: Reciprocal effectors to endothelial progenitors?. THROMBOSIS RESEARCH, 123(1), 1-4. doi:10.1016/j.thromres.2008.03.021
Circulating endothelial cells: from bench to clinical practice
Shantsila, E., Blann, A. D., & Lip, G. Y. H. (2008). Circulating endothelial cells: from bench to clinical practice. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 6(5), 865-868. doi:10.1111/j.1538-7836.2008.02918.x
New insights on endothelial progenitor cell subpopulations and their angiogenic properties
Shantsila, E., Watson, T., Tse, H. -F., & Lip, G. Y. H. (2008). New insights on endothelial progenitor cell subpopulations and their angiogenic properties. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 51(6), 669-671. doi:10.1016/j.jacc.2007.09.057
Cardioversion and remodelline in atrial, fibrillation: Insights beyond the prothrombotic state
Shantsila, E., Watson, T., & Lip, G. Y. H. (2008). Cardioversion and remodelline in atrial, fibrillation: Insights beyond the prothrombotic state. THROMBOSIS RESEARCH, 121(4), 443-445. doi:10.1016/j.thromres.2007.08.019
2007
Endothelial colony forming units: Are they a reliable marker of endothelial progenitor cell numbers?
Shantsila, E., Watson, T., Tse, H. F., & Lip, G. Y. H. (2007). Endothelial colony forming units: Are they a reliable marker of endothelial progenitor cell numbers?. ANNALS OF MEDICINE, 39(6), 474-479. doi:10.1080/07853890701329283
Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias
Shantsila, E., Watson, T., & Lip, G. Y. H. (2007). Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias. EUROPACE, 9, 37-44. doi:10.1093/europace/eum169
Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation
Watson, T., Shantsila, E., & Lip, G. Y. H. (2007). Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 120(1), 123-124. doi:10.1016/j.ijcard.2006.07.185
Antioxidant protection: yet another function of endothelial progenitor cells?
Shantsila, E., Watson, T., & Lip, G. Y. H. (2007). Antioxidant protection: yet another function of endothelial progenitor cells?. JOURNAL OF HUMAN HYPERTENSION, 21(5), 343-346. doi:10.1038/sj.jhh.1002166
In response [7]
Watson, T., Shantsila, E., & Lip, G. Y. H. (2007). In response [7]. Clinical Medicine, Journal of the Royal College of Physicians of London, 7(2), 199-200.
Modern management of atrial fibrillation - Response
Watson, T., Shantsila, E., & Lip, G. (2007). Modern management of atrial fibrillation - Response. CLINICAL MEDICINE, 7(2), 199-200. Retrieved from https://www.webofscience.com/
Standardization of circulating endothelial cell enumeration by the use of human umbilical vein endothelial cells
Goon, P. K. Y., Watson, T., Shantsila, E., Boos, C. J., & Lip, G. Y. H. (2007). Standardization of circulating endothelial cell enumeration by the use of human umbilical vein endothelial cells. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 5(4), 870-872. doi:10.1111/j.1538-7836.2007.02411.x
Aspirin resistance: What, why and when?
Shantsita, E., Watson, T., & Lip, G. Y. H. (2007). Aspirin resistance: What, why and when?. THROMBOSIS RESEARCH, 119(5), 551-554. doi:10.1016/j.thromres.2006.08.009
Endothelial progenitor cells in cardiovascular disorders
Shantsila, E., Watson, T., & Lip, G. Y. H. (2007). Endothelial progenitor cells in cardiovascular disorders. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 49(7), 741-752. doi:10.1016/j.jacc.2006.09.050
2006
Anticoagulation for stroke prevention - High effectiveness, more cost benefit?
Shantsila, E., Watson, T., & Lip, G. Y. H. (2006). Anticoagulation for stroke prevention - High effectiveness, more cost benefit?. PHARMACOECONOMICS, 24(10), 1035-1038. doi:10.2165/00019053-200624100-00010
Anticoagulation for stroke prevention in atrial fibrillation: is gender important?
Lip, G. Y. H., Watson, T., & Shantsila, E. (2006). Anticoagulation for stroke prevention in atrial fibrillation: is gender important?. EUROPEAN HEART JOURNAL, 27(16), 1893-1894. doi:10.1093/eurheartj/ehl140
Atrial fibrillation post-cardiac surgery: changing perspectives
Shantsila, E., Watson, T., & Lip, G. Y. H. (2006). Atrial fibrillation post-cardiac surgery: changing perspectives. CURRENT MEDICAL RESEARCH AND OPINION, 22(8), 1437-1441. doi:10.1185/030079906X115658
Therapy for atrial fibrillation: new challenges
Shantsila, E., Watson, T., & Lip, G. Y. H. (2006). Therapy for atrial fibrillation: new challenges. Therapy, 3(4), 445-448. doi:10.2217/14750708.3.4.445
Therapy for atrial fibrillation: new challenges
Shantsila, E., Watson, T., & Lip, G. Y. H. (2006). Therapy for atrial fibrillation: new challenges. Therapy, 3(4), 445-448. doi:10.1586/14750708.3.4.445
Pharmacotherapy for atrial fibrillation: is rhythm control achievable?
Watson, T., Shantsila, E., & Lip, G. Y. H. (2006). Pharmacotherapy for atrial fibrillation: is rhythm control achievable?. EXPERT OPINION ON PHARMACOTHERAPY, 7(9), 1105-1107. doi:10.1517/14656566.7.9.1105
2001
Laboratory investigation of platelets
Shantsila, E., Watson, T., & Lip, G. Y. H. (2001). Laboratory investigation of platelets. In Platelets in Hematologic and Cardiovascular Disorders (pp. 124-146). Cambridge University Press. doi:10.1017/cbo9780511545276.010